Research Article
SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
Figure 5
Promoter methylation levels of SLC2A5 in LUAD. Promoter methylation levels of SLC2A5 were low in (a)–(f). LUAD: (a) sample type, (b) gender, (c) race, (d) TP53 mutation status, (e) individual cancer stages, and (f) age (, , and ).
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |